Form EFFECT TFF Pharmaceuticals,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | March 7, 2025 |
| Accession Number: | 0001213900-25-021117 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Vaisala's Half Year Financial Report January–June 2026 to be published on July 21, 2026
- Colt DCS appoints David Burton as Chief Information Officer
- Danske Bank share buy-back programme: transactions in week 27
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
